Europe’s last manufacturer of ingredients for some vital antibiotics is closing its biggest domestic factory and shifting some production to China, dealing a blow to Brussels’ efforts to reduce drug dependence on Asia.
Lossmaking Xellia Pharmaceuticals said it could only survive against Chinese competition by moving many of its products to its plant there.
您已閱讀14%（531字），剩餘86%（3255字）包含更多重要資訊，訂閱以繼續探索完整內容，並享受更多專屬服務。